» Articles » PMID: 1610912

Characterization of ATP-diphosphohydrolase Activities in the Intima and Media of the Bovine Aorta: Evidence for a Regulatory Role in Platelet Activation in Vitro

Overview
Specialties Biochemistry
Biophysics
Date 1992 Jun 9
PMID 1610912
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

The inner layer of the aorta contains the enzyme ATP diphosphohydrolase (ATPDase: EC 3.6.1.5) which catalyzes the sequential phosphorolysis of ATP----ADP----AMP. Two zones of the inner layer, the intima and media, were separated and both were shown to contain ATPDase activity of similar specific activity (0.08 and 0.10 U/mg protein, respectively). However, the media exhibited about 100-times more enzyme activity than the intima. Both preparations were virtually identical with respect to pH optima (7.5), migration patterns after electrophoresis under non-denaturing conditions, relative rates of ATP and ADP hydrolysis and potency to inhibit ADP-induced platelet aggregation in both human platelet-rich plasma and whole blood. The IC50 values for ADP (2 microM)-induced aggregation were 6.8 and 12.9 mU/ml in platelet-rich plasma and whole blood, respectively. Addition of ATPDase to platelets pre-aggregated with ADP resulted in a dose-dependent disaggregation in platelet-rich plasma (IC50 4.9 mU/ml), but not in whole blood. When both ATPDase (5.6-58.7 mU/ml) and ATP (0.5-10 microM) were added to platelet-rich plasma, there was an immediate dose-dependent aggregation of platelets followed by a slowly developing disaggregation. These data show that ATPDase is present in both the intima and media layers of bovine aorta and suggest a dual role for this enzyme in platelet activation. By converting ATP released from damaged cells into ADP, the enzyme could facilitate platelet aggregation at the site of vascular injury, whereas the subsequent conversion of ADP to AMP could inhibit or reverse platelet aggregation. The consequence of these activities would be to control the growth of a platelet thrombus.

Citing Articles

Purinergic signaling in early inflammatory events of the foreign body response: modulating extracellular ATP as an enabling technology for engineered implants and tissues.

Rhett J, Fann S, Yost M Tissue Eng Part B Rev. 2013; 20(5):392-402.

PMID: 24279914 PMC: 4185977. DOI: 10.1089/ten.TEB.2013.0554.


The ecto-nucleotidase NTPDase1 differentially regulates P2Y1 and P2Y2 receptor-dependent vasorelaxation.

Kauffenstein G, Furstenau C, DOrleans-Juste P, Sevigny J Br J Pharmacol. 2010; 159(3):576-85.

PMID: 20067476 PMC: 2828022. DOI: 10.1111/j.1476-5381.2009.00566.x.


Overexpression of CD39/nucleoside triphosphate diphosphohydrolase-1 decreases smooth muscle cell proliferation and prevents neointima formation after angioplasty.

Koziak K, Bojakowska M, Robson S, Bojakowski K, Soin J, Csizmadia E J Thromb Haemost. 2008; 6(7):1191-7.

PMID: 18485080 PMC: 2761653. DOI: 10.1111/j.1538-7836.2008.03019.x.


Comparative hydrolysis of P2 receptor agonists by NTPDases 1, 2, 3 and 8.

Kukulski F, Levesque S, Lavoie E, Lecka J, Bigonnesse F, Knowles A Purinergic Signal. 2008; 1(2):193-204.

PMID: 18404504 PMC: 2096530. DOI: 10.1007/s11302-005-6217-x.


The role of purinergic signaling in the liver and in transplantation: effects of extracellular nucleotides on hepatic graft vascular injury, rejection and metabolism.

Beldi G, Enjyoji K, Wu Y, Miller L, Banz Y, Sun X Front Biosci. 2007; 13:2588-603.

PMID: 17981736 PMC: 2892180. DOI: 10.2741/2868.